Picolinic acid in patients with chronic hepatitis C infection: A preliminary report

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Zuwała Jagiello, Jolanta ^a   Pazgan Simon, Monika ^a   Simon, Krzysztof ^a   Warwas, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; PICOLINIC ACID; PICOLINIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; INFLAMMATION; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; BLOOD; METABOLISM; MIDDLE AGED;

ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PICOLINIC ACIDS; YOUNG ADULT;

EID: 84862286123     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/762863     Document Type: Article

References (45)

1. Caronia S., Taylor K., Pagliaro L., Carr C., Palazzo U., Petrik J., O'Rahilly S., Shore S., Tom B. D. M., Alexander G. J. M., Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection Hepatology 1999 30 4 1059 1063 (Pubitemid 29458297)
2. Knobler H., Schihmanter R., Zifroni A., Fenakel G., Schattner A., Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection Mayo Clinic Proceedings 2000 75 4 355 359 (Pubitemid 30187108)
3. Lecube A., Hernndez C., Genesc J., Esteban J. I., Jard R., Sim R., High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury Diabetes Care 2004 27 5 1171 1175 (Pubitemid 38579785)
4. Mehta S. H., Brancati F. L., Strathdee S. A., Pankow J. S., Netski D., Coresh J., Szklo M., Thomas D. L., Hepatitis C virus infection and incident type 2 diabetes Hepatology 2003 38 1 50 56 (Pubitemid 36775795)
5. Petit J. M., Bour J. B., Galland-Jos C., Minello A., Verges B., Guiguet M., Brun J. M., Hillon P., Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C Journal of Hepatology 2001 35 2 279 283 (Pubitemid 32803485)
6. Douglas M. W., George J., Molecular mechanisms of insulin resistance in chronic hepatitis C World Journal of Gastroenterology 2009 15 35 4356 4364
7. Devaraj S., Jialal I., Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients Free Radical Biology and Medicine 2000 29 8 790 792
8. Mller S., Martin S., Koenig W., Hanifi-Moghaddam P., Rathmann W., Haastert B., Giani G., Illig T., Thorand B., Kolb H., Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors Diabetologia 2002 45 6 805 812
9. Dandona P., Aljada A., Bandyopadhyay A., Inflammation: the link between insulin resistance, obesity and diabetes Trends in Immunology 2004 25 1 4 7 (Pubitemid 38032801)
10. Alexandraki K., Piperi C., Kalofoutis C., Singh J., Alaveras A., Kalofoutis A., Inflammatory process in type 2 diabetes: the role of cytokines Annals of the New York Academy of Sciences 2006 1084 89 117 (Pubitemid 47091972)
11. Ridker P. M., C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Moving an inflammatory hypothesis toward consensus Journal of the American College of Cardiology 2007 49 21 2129 2138 (Pubitemid 46783865)
12. Devaraj S., Singh U., Jialal I., The evolving role of C-reactive protein in atherothrombosis Clinical Chemistry 2009 55 2 229 238
13. Natali A., L'Abbate A., Ferrannini E., Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality European Heart Journal 2003 24 7 639 648 (Pubitemid 36343197)
14. Margolis K. L., Manson J. E., Greenland P., Rodabough R. J., Bray P. F., Safford M., Grimm R. H., Howard B. V., Assaf A. R., Prentice R., Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the women's health initiative observational study Archives of Internal Medicine 2005 165 5 500 508 (Pubitemid 40344380)
15. Pickup J. C., Mattock M. B., Chusney G. D., Burt D., NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 1997 40 11 1286 1292 (Pubitemid 27469668)
16. Ford E. S., The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the 3rd national health and nutrition examination survey Atherosclerosis 2003 168 2 351 358 (Pubitemid 36703335)
17. Bender D. A., Biochemistry of tryptophan in health and disease Molecular Aspects of Medicine 1983 6 2 101 197 (Pubitemid 13178235)
18. Schrcksnadel K., Wirleitner B., Winkler C., Fuchs D., Monitoring tryptophan metabolism in chronic immune activation Clinica Chimica Acta 2006 364 1-2 82 90 (Pubitemid 43120630)
19. Widner B., Weiss G., Fuchs D., Tryptophan degradation to control T-cell responsiveness Immunology Today 2000 21 5 250 (Pubitemid 30259032)
20. Varesio L., Cox G., Pulkki K., Brooks A., Melillo G., Ishiguro I., Kido R., Nagatsu T., Nagamura Y., Ohta Y., Arginine and tryptophan catabolism: the picolinic acid connection Advances in Tryptophan Research 1992 Tokyo, Japan Fujita Health University Press
21. Melillo G., Bosco M. C., Musso T., Varesio L., Immunobiology of picolinic acid Recent Advances in Tryptophan Research 1996 New York, NY, USA Plenum Press
22. Dazzi C., Candiano G., Massazza S., Ponzetto A., Varesio L., New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids Journal of Chromatography B 2001 751 1 61 68 (Pubitemid 32146314)
23. Varesio L., Espinoza-Delgado I., Gusella G., Role of cytokines in the activation of monocytes Human Cytokines: Their Role in Disease and Therapy 1995 Cambridge, Mass, USA Blackwell Scientific Publication
24. Bosco M. C., Rapisarda A., Massazza S., Melillo G., Young H., Varesio L., The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 and -1 in macrophages Journal of Immunology 2000 164 6 3283 3291 (Pubitemid 30148992)
25. Medana I. M., Day N. P. J., Salahifar-Sabet H., Stocker R., Smythe G., Bwanaisa L., Njobvu A., Kayira K., Turner G. D. H., Taylor T. E., Hunt N. H., Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria Journal of Infectious Diseases 2003 188 6 844 849 (Pubitemid 37176030)
26. Huang A., Fuchs D., Widner B., Glover C., Henderson D. C., Allen-Mersh T. G., Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer British Journal of Cancer 2002 86 11 1691 1696 (Pubitemid 34712909)
27. Forrest C. M., Youd P., Kennedy A., Gould S. R., Darlington L. G., Stone T. W., Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease Journal of Biomedical Science 2002 9 5 436 442
28. Adams D. H., Hubscher S., Fear J., Johnston J., Shaw S., Afford S., Hepatic expression of macrophage inflammatory protein-1 and macrophage inflammatory protein-1 after liver transplantation Transplantation 1996 61 5 817 825 (Pubitemid 26097246)
29. Afford S. C., Fisher N. C., Neil D. A., Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis Journal of Pathology 1998 186 1 82 89 (Pubitemid 28407492)
30. Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., Romanelli R. G., Laffi G., Gentilini P., Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration American Journal of Pathology 1998 152 2 423 430 (Pubitemid 28106388)
31. Widner B., Werner E. R., Schennach H., Wachter H., Fuchs D., Simultaneous measurement of serum tryptophan and kynurenine by HPLC Clinical Chemistry 1997 43 12 2424 2426 (Pubitemid 28022985)
32. Holtmann M. H., Neurath M. F., Differential TNF-signaling in chronic inflammatory disorders Current Molecular Medicine 2004 4 4 439 444 (Pubitemid 38787012)
33. Rehermann B., Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses Seminars in Liver Disease 2007 27 2 152 160 (Pubitemid 46871661)
34. Bosco M. C., Rapisarda A., Reffo G., Massazza S., Pastorino S., Varesio L., Macrophage activating properties of the tryptophan catabolite picolinic acid Advances in Experimental Medicine and Biology 2003 527 55 65 (Pubitemid 38197628)
35. Taylor M. W., Feng G., Relationship between interferon-, indoleamine 2,3-dioxygenase, and tryptophan catabolism FASEB Journal 1991 5 11 2516 2522 (Pubitemid 21905800)
36. Pedersen E. R., Midttun., Ueland P. M., Schartum-Hansen H., Seifert R., Igland J., Nordrehaug J. E., Ebbing M., Svingen G., Bleie., Berge R., Nygrd O., Systemic markers of interferon- -mediated immune activation and long-term prognosis in patients with stable coronary artery disease Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 3 698 704
37. Tanabe A., Egashira Y., Fukuoka S. I., Shibata K., Sanada H., Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes Journal of Nutrition 2002 132 6 1153 1159 (Pubitemid 34606443)
38. Hui J. M., Sud A., Farrell G. C., Bandara P., Byth K., Kench J. G., McCaughan G. W., George J., Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression Gastroenterology 2003 125 6 1695 1704 (Pubitemid 37500434)
39. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus Journal of the American Medical Association 2001 286 3 327 334 (Pubitemid 32656163)
40. Chung Y. M., Park K. J., Choi S. Y., Hwang S. B., Lee S. Y., Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through RAF2-IKKbeta-dependent pathway Biochemical and Biophysical Research Communications 2001 284 1 15 19 (Pubitemid 32924302)
41. Ishizaka N., Ishizaka Y., Takahashi E., Toda E. I., Hashimoto H., Ohno M., Nagai R., Yamakado M., Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers Circulation 2002 105 9 1028 1030 (Pubitemid 34212607)
42. Ye D., Zhao Y., Hildebrand R. B., Singaraja R. R., Hayden M. R., Van Berkel T. J. C., Van Eck M., The dynamics of macrophage infiltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice American Journal of Pathology 2011 178 1 413 422
43. Peters W., Charo I. F., Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice Current Opinion in Lipidology 2001 12 2 175 180 (Pubitemid 32242925)
44. Torzewski M., Rist C., Mortensen R. F., Zwaka T. P., Bienek M., Waltenberger J., Koenig W., Schmitz G., Hombach V., Torzewski J., C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 9 2094 2099
45. Pasceri V., Chang J., Willerson J. T., Yeh E. T. H., Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 2001 103 21 2531 2534 (Pubitemid 32521959)